|
The following is a newly-released NCI research funding opportunity:
Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2005-2006
PAR-05-042
Letter of Intent Receipt Dates:
Lung and genitourinary (bladder, kidney, testicular,
not prostate) cancer SPORE: Mar. 23, 2005; Skin and prostate cancer SPORE: July 23, 2005
Application Receipt Dates:
Lung and genitourinary (bladder, kidney, testicular, not prostate) cancer SPORE: May 23, 2005; Skin and prostate cancer SPORE: Sept. 23, 2005
This is a reissue of PAR-03-158, which was previously released Aug. 4, 2003. The Organ Systems Branch of the Office of Centers, Training, and Resources, NCI Office of the Director, invites grant applications for Specialized Programs of Research Excellence (SPOREs) in organ-specific cancers. A SPORE is supported through the specialized center (P50) grant mechanism.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2580.
Inquiries: Dr. Jane Fountain - jf227t@nih.gov;
Dr. Peter Ujhazy - pu5s@nih.gov; Dr. Andrew
Hruszkewycz - ah5x@nih.gov.
For comprehensive information about NCI funding priorities and opportunities,
go to http://www.cancer.gov/researchandfunding.
The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. Newly released Roadmap funding opportunities are listed below. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.
|